P939: SYNERGISTIC EFFECTS OF LOW DOSE BELANTAMAB MAFODOTIN IN COMBINATION WITH A GAMMA-SECRETASE INHIBITOR (NIROGACESTAT) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-5 STUDY

Detalles Bibliográficos
Autores principales: Nooka, A., Lonial, S., Grosicki, S., Hus, M., Song, K., Facon, T., Callander, N. S., Ribrag, V., Uttervall, K., Quach, H., Vorobyev, V., Min, C.-K., Cheng, S., Smith, L. M., Yu, J., Collingwood, T., Holkova, B., Kremer, B. E., Gupta, I. V., Richardson, P. G., Minnema, M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429688/
http://dx.doi.org/10.1097/01.HS9.0000846624.61314.38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429688/
http://dx.doi.org/10.1097/01.HS9.0000846624.61314.38

Ejemplares similares